	Efficacy and Safety of Atezolizumab Plus Bevacizumab Versus Durvalumab Plus Tremelimumab for Unresectable Hepatocellular Carcinoma in Patients With Child-Pugh Class B: A Real-World Study. Hepatol Res Ohama H, Hiraoka A, Tada T, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S, Nishimura T, Tsuji K, Ishikawa T, Tajiri K, Toyoda H, Ogawa C, Hatanaka T, Kakizaki S, Kawata K, Naganuma A, Kosaka H, Matono T, Kuroda H, Yata Y, Nishikawa H, Tanaka H, Imai M, Aoki T, Ochi H, Tamai H, Komatsu S, Ueda Y, Kim SK, Tada F, Nakamura S, Matsuura T, Nakamura Y, Yoshida O, Nouso K, Morishita A, Itokawa N, Okubo T, Arai T, Tsutsui A, Nagano T, Tanaka K, Koshiyama Y, Kanayama Y, Noritake H, Okamura J, Enomoto H, Matsui K, Kaibori M, Fukumoto T, Hiasa Y, Kudo M, Kumada T, RELPEC Group and HCC 48 Group. PMID: 41511823 [PubMed - as supplied by publisher]
	Pilot Randomized Trial of Medical Cannabis to Reduce Symptom Burden in Patients With Newly Diagnosed Advanced Pancreatic Cancer (CanPan). JCO Oncol Pract Zylla D, Chrenka E, Lin K, Gilmore G, Cowger J, Rak D, Gupta A. PMID: 41510814 [PubMed - as supplied by publisher]
	High-Grade Pancreatic Neuroendocrine Carcinoma Presenting as Dorsal Spinal Cord Compression: A Diagnostic and Surgical Challenge for the Orthopedic Oncologist. J Orthop Case Rep Choudhary R, Negi R, Bahagotia UK, Dwajan A. PMID: 41509745 [PubMed]
	Beta-Blocker Use and Survival Outcomes in Pancreatic Cancer Patients: A Systematic Review and Meta-Analysis. Clin Med Insights Oncol Li R, Chen J, Chen Y, Jin K, Chen Y, Deng C, Liu X, Li Y. PMID: 41509003 [PubMed]
	Uncovering the potential of pathomics: prognostic prediction and mechanistic investigation of pancreatic cancer. J Pathol Liu L, Zhao X, Zhang F, Huang Y, Wang Q, Fang Z, Zhu Y, Zhang Y. PMID: 41508286 [PubMed - as supplied by publisher]
	Esophageal neuroendocrine carcinoma: molecular insights, diagnostic advances, and emerging treatment strategies. Clin Transl Oncol Wu XW, Du Y, Jiao Y. PMID: 41507459 [PubMed - as supplied by publisher]
	Oncological Adequacy of R1 Vascular Margin in Minimally Invasive Liver Surgery for Hepatocellular Carcinoma and Colorectal Liver Metastases: A Meta-analysis. Ann Surg Oncol Procopio F, Memeo R, Del Fabbro D, Abdelhadi S, Reissfelder C, Edwin B, Milana F, Troisi RI, Torzilli G, Minimally Invasive R1 Vascular Group. PMID: 41507450 [PubMed - as supplied by publisher]
	Obesity and Cancer: Mechanisms, Epidemiological Evidence, and Potential Risk Reduction. J Obes Metab Syndr Lim JS, Kim S, Cho IY, Shin DW. PMID: 41506747 [PubMed - as supplied by publisher]
	Radiopathomics Signature for Prognosis and Prediction of Chemotherapy Benefit in Unresectable Pancreatic Cancer. JCO Precis Oncol Hu X, Liang K, Liu Y, Zhang Z, Liu G, Tan X. PMID: 41505682 [PubMed - indexed for MEDLINE]
	Erratum: Benefit of Chemoradiotherapy Versus Chemotherapy After Induction Therapy for Conversion of Unresectable Into Resectable Pancreatic Cancer: The Randomized CONKO-007 Trial. J Clin Oncol Fietkau R, Ghadimi M, Grützmann R, Wittel UA, Jacobasch L, Uhl W, Croner RS, Bechstein WO, Neumann UP, Waldschmidt D, Boeck S, Moosmann N, Reinacher-Schick AC, Golcher H, Adler W, Semrau S, Lubgan D, Kallies A, Hecht M, Tischoff I, Tannapfel A, Frey B, Oettle H, CONKO Study Group. PMID: 41505667 [PubMed - as supplied by publisher]
	Graphene Quantum Dots in Cancer Diagnostics and Therapeutics: Advances in Biosensing, Imaging, and Treatment Applications. Curr Med Sci Bhise MR, Trivedi V, Devi S, Tripathi AK, Kumar J, Katta S, Raval AV, Shamim S, Kumar R, Kumar P. PMID: 41505072 [PubMed - as supplied by publisher]
	Comparative study of the efficacy and safety of PSOX and SOX plus sintilimab regimens as first-line treatments for advanced gastric cancer. Anticancer Drugs Zhang T, Yang W, Zhang C, Wang K, Li H. PMID: 41503711 [PubMed - as supplied by publisher]
	Three-Dimensional Tumor Spheroids of Pancreatic and Colorectal Cancer Cell Lines for High-Throughput Screening of Drug Candidates. ACS Omega Trofimov M, Bulatov I, Donskaia I, Efremov A, Litau E, Lavrinenko V, Popov V, Petrova V, Bukatin A, Tyazhelnikov S. PMID: 41502656 [PubMed]
	Early GLP-1 Agonist Use and Cancer Risk in Type 2 Diabetes: A Real-World Data Cohort Study. Oncol Res Chuang CH, Tsai PK, Kao SW, Wang YH, Yeh CB. PMID: 41502515 [PubMed - indexed for MEDLINE]
	Perioperative tislelizumab plus lenvatinib treatment for resectable hepatocellular carcinoma at high risk of recurrence: single-arm phase II trial. Nat Commun Chen L, Zhai S, Liu Y, Gong W, Fang F, Wu Q, Cui Y, Zhang W, Li H, Li Y, Hao J, Song T. PMID: 41501032 [PubMed - as supplied by publisher]
	Re-expression of embryonic stem cell markers in malignant tissue: an observational study in pancreatic cancer. Anat Cell Biol Swain S, Rout S, Raman S, Ravi PK, Babu S, Mishra PR. PMID: 41500957 [PubMed - as supplied by publisher]
	Cross-Cancer Perspectives on CD40 Agonist Therapy: Modulating the Tumor Immune Microenvironment. J Biochem Mol Toxicol Hua X, Hua J, Wang Y. PMID: 41499321 [PubMed - indexed for MEDLINE]
	Stimuli-Responsive Supramolecular Biomaterials for Cancer Theranostics. Adv Sci (Weinh) Hu W, Ye B, Yu G, Huang F, Mao Z. PMID: 41498647 [PubMed - as supplied by publisher]
	COVID vaccination and post-infection cancer signals: Evaluating patterns and potential biological mechanisms. Oncotarget Kuperwasser C, El-Deiry WS. PMID: 41498242 [PubMed - indexed for MEDLINE]
	CRISPR-Cas13a diagnostics for circulating microbial transcripts in pancreatic cancer. Ann Med Surg (Lond) Mehmood MS, Iqbal I, Hajj F. PMID: 41496941 [PubMed]

Articles 1 - 20 / 58733

Page 1 of 2937



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy